small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search

Capabilities 32 results

Practice Area

Derivatives & Structured Products

Winston represents swap dealers, major swap participants, financial intermediaries, hedge funds, national exchanges, and end-users in a broad array of derivative transactions ranging from highly structured transactions to more traditional trading or hedging transactions, and in regulatory and enforcement issues related to commodities and derivatives....Read more

Practice Area

Structured Finance

Our structured finance group is widely recognized as a leader, encompassing Esoteric Finance, Residential Asset Finance and Securitization, and CLOs/Fund Finance. Positioned prominently at the forefront of the industry, our team boasts extensive experience across a broad spectrum of assets, with a particular focus on bespoke structures and emerging and/or “esoteric” assets, including residential and commercial PACE, RMBS, and CMBS; aircraft, vessel, and railcar finance; FinTech and marketplace lending; CLOs; specialty finance; consumer and business lending; energy structured finance (including solar finance and reserve-based finance); derivatives and structured products; lease and operating asset finance; trade receivables; litigation settlement financing; and life settlements....Read more

Practice Area

Securities, M&A & Corporate Governance Litigation

In today’s market, litigators with experience in securities, corporate governance, and M&A-related (collectively, “securities litigation”) matters need to leverage their broad experience to serve as both advocate and as counsel and strategist, focused on helping clients to overcome not just a legal issue but a collective business problem. Given the frequent interplay between things such as corporate-control transactions, public offerings, activist shareholders, the use of complex derivatives and other financial instruments, bad news impacting stock performance, regulatory inquiries and investigations, and insurance coverage, strategic and tactical litigation decisions can have a wide-ranging impact on the success of a given transaction, as well as on companies, their boards, senior management, and advisors....Read more

Experience 6 results

Experience

|

January 19, 2026

Winston Advises smartTrade Technologies Group on the Acquisition of kACE

A cross-border team from advised smartTrade Technologies Group (“smartTrade”), a leading provider of multi-asset electronic trading and payments solutions, on its acquisition of kACE Financial (“kACE”), formerly known as Fenics, a well-established provider of technology solutions for FX and interest rate derivatives pricing, analytics, and workflow management....Read more

Experience

|

January 9, 2025

Delaware Court Sees Though Plaintiffs’ Poorly Disguised Derivative Claims

Winston received an Am Law Litigator of the Week Shout Out for securing a ruling knocking out US$300M in claims against the former board of managers of Verano Holdings LLC, a subsidiary of Verano Holdings Corp., one of the country’s largest publicly traded cannabis companies. Delaware Vice Chancellor J. Travis Laster dismissed a lawsuit brought by former minority shareholders in Verano Holdings finding the plaintiffs lost standing to bring such derivative claims after the combination that resulted in the public company took hold. The judge issued a dismissal with prejudice in an oral ruling from the bench....Read more

Experience

|

January 16, 2024

Represented The Honey Pot Company Holdings, LLC, a leading better-for-you feminine care brand, in the sale of a controlling stake in the business to Compass Diversified (NYSE: CODI)

Winston & Strawn represented The Honey Pot Company Holdings, LLC (“The Honey Pot Co.”), a leading better-for-you feminine care brand in connection with the acquisition of a controlling stake in the business by Compass Diversified (NYSE: CODI) ("Compass”). Compass and The Honey Pot entered into a definitive agreement for an enterprise value of $380 million (excluding working capital and certain other adjustments upon closing). The Honey Pot Co. will continue to be led by its current leadership team and existing owners and management will retain a significant minority stake in The Honey Pot Co....Read more
View All Experience

Insights & News 231 results

Client Alert

|

February 19, 2026

|

4 Min Read

Upcoming Registration and Reporting Deadlines for VC Funds with CA Nexus

Under California’s Fair Investment Practices by Venture Capital Companies Law (the FIPVCC), venture capital funds with a nexus to California (Covered Entities) will be required to register with the California Department of Financial Protection & Innovation (the DFPI) starting in March 2026 and report demographic information about their portfolio companies to the DFPI starting in April 2026. The purpose of the FIPVCC is to increase transparency regarding the demographics of the founding teams of the portfolio companies in which Covered Entities invest.

Capital Markets & Securities Law Watch

|

November 18, 2025

|

3 Min Read

SEC Chairman Atkins Signals Major Shift: Potential Token Taxonomy and Evolving Application of Howey Test to Crypto Assets

In an address delivered on November 12, 2025 at the Federal Reserve Bank of Philadelphia, Securities and Exchange Commission (SEC or Commission) Chairman Paul S. Atkins outlined the next phase of the SEC’s “Project Crypto,” advocating for clarity and fairness in the regulation of digital assets.

Client Alert

|

November 12, 2025

|

3 Min Read

Take Notice: California Expands Healthcare Transaction Notification Regime

Just five days after tightening restrictions on the corporate practice of medicine for hedge funds and private equity groups, on October 11, 2025, California Governor Gavin Newsom signed Assembly Bill 1415 (AB 1415) into law, expanding the types of entities and transactions that must be reported to the California Office of Health Care Affordability (OHCA) under the state’s healthcare transaction review law....Read more
View All Insights & News

Other Results 17 results

Law Glossary

What Is the Patent Trial and Appeal Board?

The Patent Trial and Appeal Board (PTAB) is a tribunal within U.S. Patent and Trademark Office. The PTAB oversees trial proceedings, namely: inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and derivation proceedings. The Board also hears appeals from adverse patentability decisions by patent examiners in original applications, reissues, and reexaminations. And, while phasing out since the passage of the America Invents Act (AIA) in 2011, the PTAB is also responsible for deciding interferences. The PTAB was previously referred to as the Board of Patent Appeals and Interferences and was renamed by the AIA....Read more

Law Glossary

What Is a Biologic?

A biologic—or biologic product—is a medicine made from or by living cells, typically through a series of complex processing steps. The Public Health Service Act defines a “biological product” as “a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or another trivalent organic arsenic compound), applicable to the prevention, treatment, or cure of a disease or condition of human beings.” (42 U.S.C. § 262(i).)...Read more

Site Content

What Is the Dodd-Frank Act?

The full name of the Dodd-Frank Act is the Dodd-Frank Wall Street Reform and Consumer Protection Act. It was passed in 2010 to regulate the financial market and protect consumers from risky financial practices. The legislation and its rules cover the following:...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising